{
"info": {
"nct_id": "NCT05651282",
"official_title": "Uterine Cancer Risk Reducing Strategies in Postmenopausal Women",
"inclusion_criteria": "* Individuals are postmenopausal (must be three (3) years past last menstrual period)\n* Individuals have an intact uterus (have not had a hysterectomy)\nHealthy volunteers allowed\nMust be FEMALE",
"exclusion_criteria": "* Individuals taking hormone therapy for menopause (including vaginal estrogen)\n* Individuals taking male hormones,\n* Individuals on anti-endocrine therapy (such as tamoxifen)\n* Individuals on aromatase inhibitor therapy\n* Individuals who have experienced abnormal uterine bleeding\n* Individuals who have an Intrauterine Device (IUD)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Individuals are postmenopausal (must be three (3) years past last menstrual period)",
"criterions": [
{
"exact_snippets": "Individuals are postmenopausal (must be three (3) years past last menstrual period)",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "postmenopausal"
},
{
"requirement_type": "time since last menstrual period",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Individuals have an intact uterus (have not had a hysterectomy)",
"criterions": [
{
"exact_snippets": "intact uterus (have not had a hysterectomy)",
"criterion": "uterus status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Individuals taking hormone therapy for menopause (including vaginal estrogen)",
"criterions": [
{
"exact_snippets": "Individuals taking hormone therapy for menopause",
"criterion": "hormone therapy for menopause",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "(including vaginal estrogen)",
"criterion": "vaginal estrogen",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Individuals taking male hormones,",
"criterions": [
{
"exact_snippets": "Individuals taking male hormones",
"criterion": "male hormone usage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Individuals on anti-endocrine therapy (such as tamoxifen)",
"criterions": [
{
"exact_snippets": "Individuals on anti-endocrine therapy (such as tamoxifen)",
"criterion": "anti-endocrine therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Individuals on aromatase inhibitor therapy",
"criterions": [
{
"exact_snippets": "Individuals on aromatase inhibitor therapy",
"criterion": "aromatase inhibitor therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Individuals who have experienced abnormal uterine bleeding",
"criterions": [
{
"exact_snippets": "abnormal uterine bleeding",
"criterion": "abnormal uterine bleeding",
"requirements": [
{
"requirement_type": "experience",
"expected_value": true
}
]
}
]
},
{
"line": "* Individuals who have an Intrauterine Device (IUD)",
"criterions": [
{
"exact_snippets": "Individuals who have an Intrauterine Device (IUD)",
"criterion": "Intrauterine Device (IUD)",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}